Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New

Description

Insights Into the Generic Drugs Market in Canada

Flovent asthma inhaler to be discontinued in favor of generic brand

GlaxoSmithKline, Pfizer deal brings Advil, Tums together in

Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die

Haleon emerges from GSK consumer healthcare spin-off

Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New

The top 10 drugs losing US exclusivity in 2023

Generic advertising definition, generic

GlaxoSmithKline to stop seeking patents in world's poorest countries

Glaxo Settles Cases With U.S. for $3 Billion - The New York Times

GSK company focus: turning the ship around

Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New

New GSK maintains strong start, but Zantac litigation looms large

Solved GlaxoSmithKline (GSK) - strategy influenced by

$ 27.99USD
Score 4.5(173)
In stock
Continue to book